RT Journal Article
SR Electronic
T1 Challenge to levetiracetam’s de facto position as generic first-line antiseizure medication
JF Practical Neurology
JO Pract Neurol
FD BMJ Publishing Group Ltd
SP practneurol-2021-003217
DO 10.1136/practneurol-2021-003217
A1 Aidan Neligan
A1 Matthew Walker
A1 Sanjeev Rajakulendran
YR 2021
UL http://pn.bmj.com/content/early/2021/10/05/practneurol-2021-003217.abstract
AB